Compensation award — excluded from discretionary-purchase analysis.
Signed Jan 29, 2026 · Updated Feb 3, 2026
The Department of Defense placed a delivery order with Pfizer for naloxone vials, committing $2.8K so far. This order was made under an existing larger agreement and was open to any bidder, making it a routine purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$2,820
Actual federal dollars obligated to date on this award
$2,820
A maximum, not earned revenue
$652K across 10 awards
Obligations to date on awards newly signed in the last 12 months, mapped to this company
83.2% from the largest awarding agency
Share of T12M mapped obligations
#8 of 10 mapped awards by obligations
Within the awards OQRO has ingested
0.00% of FY2021 revenue ($81.3B)
T12M mapped obligations ÷ revenue the company reported in its 10-K. A size comparison: obligations are not revenue and are usually earned over several years
verified alias
Exact identifier > verified alias > manual override
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.